Navigation Links
Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
Date:4/23/2009

LOS ANGELES (April 23, 2009) The Food and Drug Administration (FDA) gave its approval this week for Emmaus Medical, Inc. to begin a Phase 3 clinical trial of an experimental treatment for sickle cell disease. The patented experimental treatment was originally developed by investigators led by Yutaka Niihara, MD, MPH, at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and is licensed to Emmaus Medical.

The patented drug treatment involves the oral administration of L-glutamine, which is the most common amino acid in the body. This is one of a very few experimental treatments for sickle cell disease to reach the Phase 3 clinical trial stage.

"News of this clinical trial should be of great interest to the millions of people around the world who suffer from painful crises caused by sickle cell disease," said Dr. Niihara. "Phase 3 clinical trials are large, randomized studies conducted at multiple sites to determine the safety and efficacy of a potential treatment. Phase 3 clinical trials are usually the last clinical trials conducted before FDA approval is obtained and the treatment can be made widely available to the patient population."

Sickle cell disease is an inherited disorder that causes red blood cells to become oxidized, sticky and sickle shaped instead of smooth, pliable and round. Sickle cell disease leads to anemia, organ damage, chronic and acute pain and a host of other problems.

"In our Phase 2 clinical trial, we observed an excellent safety profile and positive trends in reducing the number of crises and hospitalizations in sickle cell disease patients," said Dr. Niihara. "We look forward to initiating the Phase 3 clinical trial and remain committed to developing a treatment for sickle cell disease."


'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Page: 1

Related medicine news :

1. Anticlotting drug found to be safe in sickle cell patients
2. New Kind of Stem Cells Reverse Sickle Cell Anemia
3. Children with sickle cell disease, silent strokes show some relief with blood transfusions
4. Sickle Cell Disease Pain Can Occur Daily and Is Much More Severe Than Previously Thought
5. Sickle Cell Patients in More Pain Than Thought
6. UT Southwestern researchers investigate predictors for sickle-cell-anemia complications
7. For children with sickle cell disease, lung disease is part of the package
8. Lung Trouble Associated With Sickle Cell in Kids
9. Researchers Develop Stem Line With Sickle Cell Mutation
10. Effective treatment for sickle cell underused by doctors
11. Sickle Cell Drug Underused by Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sickle cell treatment developed at LA BioMed approved for phase 3 clinical trial
(Date:6/1/2015)... The Muscular Dystrophy Association is offering an ... the sold out 2015 Bank of America Chicago ... by signing up through the organization's nationwide endurance ... , This national endurance program includes world-class training ... a supportive community of teammates, volunteers, coaches and ...
(Date:6/1/2015)... Portland, Ore. (PRWEB) June 01, 2015 ... Plans (AHIP) announced today a new, interactive Affordable ... support large employers. The course, called “Affordable Care ... care professionals with the strategic and consultative insights ... employers as they navigate the impacts of the ...
(Date:6/1/2015)... a leading web-base electronic healthcare software (EHR) is providing ... Louisiana. The entrepreneurial trio behind Sharenote, will travel to ... with the tools and resources to monitor key performance ... , Find out why Sharenote is the EHR ... 250 practices. , Four Day Schedule , ...
(Date:6/1/2015)... June 01, 2015 KC and Monica ... $88,000 of the best superfood products in ... floods in Texas. , "Monica and I are ... News in distributing Living Fuel Super Meals - SuperBerry®, ... millennial floods in Texas," KC Craichy said. "We have ...
(Date:6/1/2015)... FL (PRWEB) June 01, 2015 More than ... the summer months when school is out and they lose ... Dairy Month and America’s dairy farmers and milk companies are ... in need with The Great American Milk Drive. , ... milk provided in the school cafeteria for the bulk of ...
Breaking Medicine News(10 mins):Health News:Sold Out 2015 Bank of America Chicago Marathon and Marine Corps Marathon Entries Still Available through MDA Team Momentum 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2
... West Anaheim Medical,Center, an affiliate of Prime ... patient tracking and integrated data system,within the ... the application is called Emergency Department Management ... their Emergency Department,patients quickly and efficiently. This ...
... Implant Dentistry (AAID), www.aaid.com , WHAT: Annual ... Dentistry , WHEN: Nov 7 11, 2007 , ... WHY: Dental implants are the hottest procedure in dentistry, ... for patients from adolescents to seniors. Implant growth in ...
... 30 Global Healthcare Alliance, Inc., a,web-based ... claims,processing, has been selected by St. Luke,s ... Luke,s Medical Clinic, as its enterprise,medical billing ... was selected by St. Luke,s,Medical Clinic because ...
... Portrayals of bipolar,disorder seem to be cropping ... and,on television. The November 2007 issue of the ... this condition., Bipolar disorder is difficult to ... illnesses. Because mania is the hallmark of bipolar,disorder, ...
... in 4 Americans has,diabetes or is at risk for ... The following,release was issued today by the American ... (ADA) American Diabetes Month(R),brings to light the fastest growing ... million Americans have diabetes or are at risk of,developing ...
... effectiveness without boosting this side effect, study finds , , ... undergoing a high-tech form of radiation therapy, exposure to a ... no added risk for impaired sexual function, new research reveals. ... a shorter amount of time than is typical -- meaning ...
Cached Medicine News:Health News:Hospital Launches State-of-the-Art Patient Tracking and Integrated Patient Data System 2Health News:American Academy of Implant Dentistry 2Health News:New St. Luke's Medical Clinic Selects Award-Winning globalcentara Provider(SM) by Houston's Global Healthcare Alliance 2Health News:Misconceptions About Bipolar Disorder Explained, From the Harvard Health Letter 2Health News:American Diabetes Month(R) Brings Awareness to Growing Health Care Crisis 2Health News:High Dose Radiation for Prostate Cancer Won't Raise Sexual Dysfunction 2Health News:High Dose Radiation for Prostate Cancer Won't Raise Sexual Dysfunction 3
(Date:6/1/2015)... OAKS, Calif. , June 2, 2015 /PRNewswire/ ... a collaboration with Roche on a Phase 1b ... talimogene laherparepvec, Amgen,s investigational oncolytic immunotherapy, in combination ... as MPDL3280A), in patients with triple-negative breast cancer ... Talimogene laherparepvec is an investigational oncolytic immunotherapy designed ...
(Date:6/1/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: ... on Omega-3 therapies for cardiovascular disease (CVD) and ... results for the three months ended March 31, ... Canadian dollars unless otherwise stated. "Pivotal ... its limited financial resources," stated Mr. Eugenio ...
(Date:6/1/2015)... , June 1, 2015  Research Solutions, Inc. (OTCQB: ... and medical (STM) information for life science companies, academic ... to present at the LD Micro Invitational being held ... in Los Angeles . ... on Wednesday, June 3rd at 9:30 a.m. Pacific time, ...
Breaking Medicine Technology:Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 2Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 3Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 4Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 5Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 6Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab 7Pivotal Therapeutics Announces First Quarter Financial Results 2Pivotal Therapeutics Announces First Quarter Financial Results 3Pivotal Therapeutics Announces First Quarter Financial Results 4Pivotal Therapeutics Announces First Quarter Financial Results 5Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3
... CTi Wrist OTS is an off-the-shelf wrist orthotic designed ... of 3 pre-set ranges-of-motion (20°,35° and 50°). , ... sprains with TFCC tear-triangular fibrocartilage complex , ... nonunion , Partial tendon rupture , ...
... The CTi Wrist Static is a solid, one-piece ... in a stable, neutral position. , ,Indications: , ... TFCC tear-triangular fibrocartilage complex , Coles fracture ... , Partial tendon rupture , ORIF ...
The Universal Wrist/Forearm Splint is ideal for post-surgical immobilization, post-fracture casting, wrist sprains and strains....
... wrist orthotic designed to limit the extension of the ... ,Indications: , Wrist reconstruction , Wrist ... Coles fracture - distal radius , Scaphoid ... ORIF - Open reduction and internal fixation for ...
Medicine Products: